# Brugada diagnosis -- leave title blank below
#+TITLE:  
#+AUTHOR:    David Mann
#+EMAIL:     mannd@epstudiossoftware.com
#+DATE:      [2017-09-24 Sun]
#+DESCRIPTION:
#+KEYWORDS:
#+LANGUAGE:  en
#+OPTIONS:   H:3 num:nil toc:nil \n:nil @:t ::t |:t ^:t -:t f:t *:t <:t
#+OPTIONS:   TeX:t LaTeX:t skip:nil d:nil todo:t pri:nil tags:not-in-toc
#+INFOJS_OPT: view:nil toc:nil ltoc:t mouse:underline buttons:0 path:http://orgmode.org/org-info.js
#+EXPORT_SELECT_TAGS: export
#+EXPORT_EXCLUDE_TAGS: noexport
#+LINK_UP:   
#+LINK_HOME: 
#+XSLT:
* HRS/EHRA/APHRS Expert Consensus Diagnostic Criteria for Brugada Syndrome (2013)
1. Brugada syndrome is diagnosed in patients with ST-segment elevation with type 1 morphology _>_ 2 mm in _>_ 1 lead among the right precordial leads V1, V2, positioned in the 2nd, 3rd, or 4th intercostal space occurring either spontaneously or after provocative drug test with intravenous administration of Class I antiarrhythmic drugs.
2. Brugada syndrome is diagnosed in patients with type 2 or type 3 ST-segment elevation with _>_ 1 lead among the right precordial leads V1, V2, positioned in the 2nd, 3rd, or 4th intercostal space occurring when a provocative drug test with intravenous administration of Class I antiarrhythmic drugs induces a type 1 ECG morphology.
** Reference
Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013;10(12):1932â€“1963. http://dx.doi.org/10.1016/j.hrthm.2013.05.014
